Skip to Main Content

Paper Details

The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
Atherosclerosis
56
2015
(18)FDG, Arterial inflammation, BMS-582949, CRP, FDG, P38 MAPK, P38 mitogen-activated protein kinase, arterial inflammation, atherosclerosis, atherosclerotic plaque inflammation, atherosclerotic plaques, atherothrombosis, atorvastatin, hs-CRP, p38 mitogen-activated protein kinase, p38MAPK, statin
Author NameAffiliation
Zahi A FayadTranslational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai
Christie M BallantyneBaylor College of Medicine and Houston Methdodist DeBakey Heart and Vascular Center
Christie M BallantyneBaylor College of Medicine and Houston Methdodist DeBakey Heart and Vascular Center
Emile R MohlerHospital of the University of Pennsylvania
  • 1 - 4

Datasets

Release 1.2